世界の四肢麻痺治療市場予測2023-2029:経口型、点滴型、その他

【英語タイトル】Quadriplegia Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2218)・商品コード:MMG23FB2218
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:68
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の四肢麻痺治療市場規模と予測を収録しています。・世界の四肢麻痺治療市場:売上、2018年-2023年、2024年-2029年
・世界の四肢麻痺治療市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の四肢麻痺治療市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

四肢麻痺治療のグローバル主要企業は、Merck、Sanofi Pharmaceuticals、Baxter International、Zydus Cadila、GlaxoSmithKline、AstraZeneca、Cipla、Johnson & Johnson、Bristol Myers Squibb、Eli Lily、Teva Pharmaceuticals、Takeda Pharmaceutical、Hoffmann La Roche、Sun Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、四肢麻痺治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の四肢麻痺治療市場:タイプ別、2018年-2023年、2024年-2029年
世界の四肢麻痺治療市場:タイプ別市場シェア、2022年
・経口型、点滴型、その他

世界の四肢麻痺治療市場:用途別、2018年-2023年、2024年-2029年
世界の四肢麻痺治療市場:用途別市場シェア、2022年
・病院薬局、小売店、ドラッグストア、オンラインストア

世界の四肢麻痺治療市場:地域・国別、2018年-2023年、2024年-2029年
世界の四肢麻痺治療市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における四肢麻痺治療のグローバル売上、2018年-2023年
・主要企業における四肢麻痺治療のグローバル売上シェア、2022年
・主要企業における四肢麻痺治療のグローバル販売量、2018年-2023年
・主要企業における四肢麻痺治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、Sanofi Pharmaceuticals、Baxter International、Zydus Cadila、GlaxoSmithKline、AstraZeneca、Cipla、Johnson & Johnson、Bristol Myers Squibb、Eli Lily、Teva Pharmaceuticals、Takeda Pharmaceutical、Hoffmann La Roche、Sun Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
四肢麻痺治療市場の定義
市場セグメント
世界の四肢麻痺治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の四肢麻痺治療市場規模
世界の四肢麻痺治療市場規模:2022年 VS 2029年
世界の四肢麻痺治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの四肢麻痺治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の四肢麻痺治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:経口型、点滴型、その他
四肢麻痺治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院薬局、小売店、ドラッグストア、オンラインストア
四肢麻痺治療の用途別グローバル売上・予測

・地域別市場分析
地域別四肢麻痺治療市場規模 2022年と2029年
地域別四肢麻痺治療売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Merck、Sanofi Pharmaceuticals、Baxter International、Zydus Cadila、GlaxoSmithKline、AstraZeneca、Cipla、Johnson & Johnson、Bristol Myers Squibb、Eli Lily、Teva Pharmaceuticals、Takeda Pharmaceutical、Hoffmann La Roche、Sun Pharmaceuticals

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Quadriplegia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Quadriplegia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Quadriplegia Treatment Overall Market Size
2.1 Global Quadriplegia Treatment Market Size: 2022 VS 2029
2.2 Global Quadriplegia Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Quadriplegia Treatment Players in Global Market
3.2 Top Global Quadriplegia Treatment Companies Ranked by Revenue
3.3 Global Quadriplegia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Quadriplegia Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Quadriplegia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Quadriplegia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Quadriplegia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Quadriplegia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Quadriplegia Treatment Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Intravenous
4.1.4 Others
4.2 By Type – Global Quadriplegia Treatment Revenue & Forecasts
4.2.1 By Type – Global Quadriplegia Treatment Revenue, 2018-2023
4.2.2 By Type – Global Quadriplegia Treatment Revenue, 2024-2029
4.2.3 By Type – Global Quadriplegia Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Quadriplegia Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Drug Stores
5.1.5 Online Stores
5.2 By Application – Global Quadriplegia Treatment Revenue & Forecasts
5.2.1 By Application – Global Quadriplegia Treatment Revenue, 2018-2023
5.2.2 By Application – Global Quadriplegia Treatment Revenue, 2024-2029
5.2.3 By Application – Global Quadriplegia Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Quadriplegia Treatment Market Size, 2022 & 2029
6.2 By Region – Global Quadriplegia Treatment Revenue & Forecasts
6.2.1 By Region – Global Quadriplegia Treatment Revenue, 2018-2023
6.2.2 By Region – Global Quadriplegia Treatment Revenue, 2024-2029
6.2.3 By Region – Global Quadriplegia Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Quadriplegia Treatment Revenue, 2018-2029
6.3.2 US Quadriplegia Treatment Market Size, 2018-2029
6.3.3 Canada Quadriplegia Treatment Market Size, 2018-2029
6.3.4 Mexico Quadriplegia Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Quadriplegia Treatment Revenue, 2018-2029
6.4.2 Germany Quadriplegia Treatment Market Size, 2018-2029
6.4.3 France Quadriplegia Treatment Market Size, 2018-2029
6.4.4 U.K. Quadriplegia Treatment Market Size, 2018-2029
6.4.5 Italy Quadriplegia Treatment Market Size, 2018-2029
6.4.6 Russia Quadriplegia Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Quadriplegia Treatment Market Size, 2018-2029
6.4.8 Benelux Quadriplegia Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Quadriplegia Treatment Revenue, 2018-2029
6.5.2 China Quadriplegia Treatment Market Size, 2018-2029
6.5.3 Japan Quadriplegia Treatment Market Size, 2018-2029
6.5.4 South Korea Quadriplegia Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Quadriplegia Treatment Market Size, 2018-2029
6.5.6 India Quadriplegia Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Quadriplegia Treatment Revenue, 2018-2029
6.6.2 Brazil Quadriplegia Treatment Market Size, 2018-2029
6.6.3 Argentina Quadriplegia Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Quadriplegia Treatment Revenue, 2018-2029
6.7.2 Turkey Quadriplegia Treatment Market Size, 2018-2029
6.7.3 Israel Quadriplegia Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Quadriplegia Treatment Market Size, 2018-2029
6.7.5 UAE Quadriplegia Treatment Market Size, 2018-2029
7 Quadriplegia Treatment Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Quadriplegia Treatment Major Product Offerings
7.1.4 Merck Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Sanofi Pharmaceuticals
7.2.1 Sanofi Pharmaceuticals Company Summary
7.2.2 Sanofi Pharmaceuticals Business Overview
7.2.3 Sanofi Pharmaceuticals Quadriplegia Treatment Major Product Offerings
7.2.4 Sanofi Pharmaceuticals Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.2.5 Sanofi Pharmaceuticals Key News & Latest Developments
7.3 Baxter International
7.3.1 Baxter International Company Summary
7.3.2 Baxter International Business Overview
7.3.3 Baxter International Quadriplegia Treatment Major Product Offerings
7.3.4 Baxter International Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.3.5 Baxter International Key News & Latest Developments
7.4 Zydus Cadila
7.4.1 Zydus Cadila Company Summary
7.4.2 Zydus Cadila Business Overview
7.4.3 Zydus Cadila Quadriplegia Treatment Major Product Offerings
7.4.4 Zydus Cadila Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.4.5 Zydus Cadila Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Quadriplegia Treatment Major Product Offerings
7.5.4 GlaxoSmithKline Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Quadriplegia Treatment Major Product Offerings
7.6.4 AstraZeneca Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Quadriplegia Treatment Major Product Offerings
7.7.4 Cipla Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.7.5 Cipla Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Quadriplegia Treatment Major Product Offerings
7.8.4 Johnson & Johnson Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Quadriplegia Treatment Major Product Offerings
7.9.4 Bristol Myers Squibb Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Key News & Latest Developments
7.10 Eli Lily
7.10.1 Eli Lily Company Summary
7.10.2 Eli Lily Business Overview
7.10.3 Eli Lily Quadriplegia Treatment Major Product Offerings
7.10.4 Eli Lily Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.10.5 Eli Lily Key News & Latest Developments
7.11 Teva Pharmaceuticals
7.11.1 Teva Pharmaceuticals Company Summary
7.11.2 Teva Pharmaceuticals Business Overview
7.11.3 Teva Pharmaceuticals Quadriplegia Treatment Major Product Offerings
7.11.4 Teva Pharmaceuticals Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.11.5 Teva Pharmaceuticals Key News & Latest Developments
7.12 Takeda Pharmaceutical
7.12.1 Takeda Pharmaceutical Company Summary
7.12.2 Takeda Pharmaceutical Business Overview
7.12.3 Takeda Pharmaceutical Quadriplegia Treatment Major Product Offerings
7.12.4 Takeda Pharmaceutical Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.12.5 Takeda Pharmaceutical Key News & Latest Developments
7.13 Hoffmann La Roche
7.13.1 Hoffmann La Roche Company Summary
7.13.2 Hoffmann La Roche Business Overview
7.13.3 Hoffmann La Roche Quadriplegia Treatment Major Product Offerings
7.13.4 Hoffmann La Roche Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.13.5 Hoffmann La Roche Key News & Latest Developments
7.14 Sun Pharmaceuticals
7.14.1 Sun Pharmaceuticals Company Summary
7.14.2 Sun Pharmaceuticals Business Overview
7.14.3 Sun Pharmaceuticals Quadriplegia Treatment Major Product Offerings
7.14.4 Sun Pharmaceuticals Quadriplegia Treatment Revenue in Global Market (2018-2023)
7.14.5 Sun Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Quadriplegia Treatment Market Opportunities & Trends in Global Market
Table 2. Quadriplegia Treatment Market Drivers in Global Market
Table 3. Quadriplegia Treatment Market Restraints in Global Market
Table 4. Key Players of Quadriplegia Treatment in Global Market
Table 5. Top Quadriplegia Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Quadriplegia Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Quadriplegia Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Quadriplegia Treatment Product Type
Table 9. List of Global Tier 1 Quadriplegia Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Quadriplegia Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Quadriplegia Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Quadriplegia Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Quadriplegia Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Quadriplegia Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Quadriplegia Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Quadriplegia Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Quadriplegia Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Quadriplegia Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Quadriplegia Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Quadriplegia Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Quadriplegia Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Quadriplegia Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Quadriplegia Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Quadriplegia Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Quadriplegia Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Quadriplegia Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Quadriplegia Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Quadriplegia Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Quadriplegia Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Quadriplegia Treatment Product Offerings
Table 32. Merck Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Sanofi Pharmaceuticals Company Summary
Table 35. Sanofi Pharmaceuticals Quadriplegia Treatment Product Offerings
Table 36. Sanofi Pharmaceuticals Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Pharmaceuticals Key News & Latest Developments
Table 38. Baxter International Company Summary
Table 39. Baxter International Quadriplegia Treatment Product Offerings
Table 40. Baxter International Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Baxter International Key News & Latest Developments
Table 42. Zydus Cadila Company Summary
Table 43. Zydus Cadila Quadriplegia Treatment Product Offerings
Table 44. Zydus Cadila Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Zydus Cadila Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Quadriplegia Treatment Product Offerings
Table 48. GlaxoSmithKline Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Quadriplegia Treatment Product Offerings
Table 52. AstraZeneca Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Cipla Company Summary
Table 55. Cipla Quadriplegia Treatment Product Offerings
Table 56. Cipla Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Cipla Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Quadriplegia Treatment Product Offerings
Table 60. Johnson & Johnson Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Bristol Myers Squibb Company Summary
Table 63. Bristol Myers Squibb Quadriplegia Treatment Product Offerings
Table 64. Bristol Myers Squibb Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol Myers Squibb Key News & Latest Developments
Table 66. Eli Lily Company Summary
Table 67. Eli Lily Quadriplegia Treatment Product Offerings
Table 68. Eli Lily Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lily Key News & Latest Developments
Table 70. Teva Pharmaceuticals Company Summary
Table 71. Teva Pharmaceuticals Quadriplegia Treatment Product Offerings
Table 72. Teva Pharmaceuticals Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Teva Pharmaceuticals Key News & Latest Developments
Table 74. Takeda Pharmaceutical Company Summary
Table 75. Takeda Pharmaceutical Quadriplegia Treatment Product Offerings
Table 76. Takeda Pharmaceutical Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Takeda Pharmaceutical Key News & Latest Developments
Table 78. Hoffmann La Roche Company Summary
Table 79. Hoffmann La Roche Quadriplegia Treatment Product Offerings
Table 80. Hoffmann La Roche Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Hoffmann La Roche Key News & Latest Developments
Table 82. Sun Pharmaceuticals Company Summary
Table 83. Sun Pharmaceuticals Quadriplegia Treatment Product Offerings
Table 84. Sun Pharmaceuticals Quadriplegia Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Sun Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Quadriplegia Treatment Segment by Type in 2022
Figure 2. Quadriplegia Treatment Segment by Application in 2022
Figure 3. Global Quadriplegia Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Quadriplegia Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Quadriplegia Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Quadriplegia Treatment Revenue in 2022
Figure 8. By Type - Global Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Quadriplegia Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Quadriplegia Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 16. US Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 28. China Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Quadriplegia Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Quadriplegia Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Pharmaceuticals Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Baxter International Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Zydus Cadila Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cipla Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol Myers Squibb Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lily Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Teva Pharmaceuticals Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Takeda Pharmaceutical Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Hoffmann La Roche Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sun Pharmaceuticals Quadriplegia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の四肢麻痺治療市場予測2023-2029:経口型、点滴型、その他] (コード:MMG23FB2218)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の四肢麻痺治療市場予測2023-2029:経口型、点滴型、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆